Polar Asset Management Partners Inc. Point Biopharma Global Inc. Transaction History

Polar Asset Management Partners Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.67 - $9.71 $949,808 - $1.38 Million	142,400 Added 60.01%	379,700 $2.53 Million
Q4 2022 Feb 14, 2023	SELL	$5.72 - $9.78 $649,792 - $1.11 Million	-113,600 Reduced 32.37%	237,300 $1.73 Million
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $1.07 Million - $1.52 Million	147,900 Added 72.86%	350,900 $2.71 Million
Q2 2022 Aug 15, 2022	BUY	$5.6 - $9.5 $1.14 Million - $1.93 Million	203,000 New	203,000 $1.38 Million

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.